国际多中心联盟对脑硬膜动静脉瘘立体定向放射外科治疗的评估
该国际多中心研究汇总114例接受伽玛刀放射外科(GKRS)治疗的脑硬膜动静脉瘘(dAVF)患者数据,总体闭塞率68.4%,有利结局63.2%。海绵窦颈动脉位置和无静脉扩张是闭塞预测因素,中颅窝/天幕位置和边缘剂量大于23 Gy与有利结局可能性降低相关,常用分级量表不能预测结局。
要点
- GKRS治疗脑dAVF总体闭塞率68.4%,有利结局率63.2%。
- 海绵窦颈动脉位置(OR 2.1)和无静脉扩张(OR 3.4)预测瘘闭塞。
- 中颅窝/天幕位置(OR 2.4)和边缘剂量大于23 Gy(OR 2.6)与有利结局可能性降低相关。
核心结论
- GKRS治疗脑dAVF在多数患者中实现闭塞并避免永久性并发症。
- 海绵窦颈动脉位置和无静脉扩张的患者放射外科后瘘闭塞可能性更高。
- 常用分级量表不能可靠预测放射外科后结局。
研究设计与样本
- 国际多中心研究,汇总国际伽玛刀研究基金会114例接受GKRS治疗的脑dAVF患者数据。
- 有利结局定义为dAVF闭塞且无治疗后出血或永久性症状性放射诱导并发症。
- 采用多变量逻辑回归分析确定结局预测因素,竞争风险生存分析计算dAVF闭塞率,Youden指数确定最佳放射外科剂量。
主要发现
- 平均边缘剂量21.8 Gy,平均随访4年(范围0.5-18年)。
- 总体闭塞率68.4%;放射外科后3、5、7、10年 actuarial 闭塞率分别为41.3%、61.1%、70.1%、82.0%。
- 放射外科后出血4例(年风险0.9%)。
- 放射诱导影像学改变发生率10.4%,其中5.2%有症状,3.5%有永久性神经功能缺损。
- 有利结局率63.2%。
关键数值与推荐
- 中颅窝和天幕dAVF患者有利结局可能性降低(OR 2.4,p=0.048)。
- 边缘剂量大于23 Gy的患者有利结局可能性降低(OR 2.6,p=0.030)。
- 女性(OR 1.7,p=0.03)、无静脉扩张(OR 3.4,p<0.001)、海绵窦颈动脉位置(OR 2.1,p=0.019)是GKRS诱导dAVF闭塞的预测因素。
- 常用分级量表(如Borden和Cognard)不能预测结局。
临床怎么用
- 对于脑dAVF患者,GKRS可实现瘘闭塞并避免永久性并发症。
- 海绵窦颈动脉位置和无静脉扩张的患者放射外科后瘘闭塞可能性更高。
- 常用分级量表不能可靠预测放射外科后结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this multicenter study, the authors reviewed the results obtained in patients who underwent Gamma Knife radiosurgery (GKRS) for dural arteriovenous fistulas (dAVFs) and determined predictors of outcome. METHODS: Data from a cohort of 114 patients who underwent GKRS for cerebral dAVFs were compiled from the International Gamma Knife Research Foundation. Favorable outcome was defined as dAVF obliteration and no posttreatment hemorrhage or permanent symptomatic radiation-induced complications. Patient and dAVF characteristics were assessed to determine predictors of outcome in a multivariate logistic regression analysis; dAVF-free obliteration was calculated in a competing-risk survival analysis; and Youden indices were used to determine optimal radiosurgical dose. RESULTS: A mean margin dose of 21.8 Gy was delivered. The mean follow-up duration was 4 years (range 0.5-18 years). The overall obliteration rate was 68.4%. The postradiosurgery actuarial rates of obliteration at 3, 5, 7, and 10 years were 41.3%, 61.1%, 70.1%, and 82.0%, respectively. Post-GRKS hemorrhage occurred in 4 patients (annual risk of 0.9%). Radiation-induced imaging changes occurred in 10.4% of patients; 5.2% were symptomatic, and 3.5% had permanent deficits. Favorable outcome was achieved in 63.2% of patients. Patients with middle fossa and tentorial dAVFs (OR 2.4, p = 0.048) and those receiving a margin dose greater than 23 Gy (OR 2.6, p = 0.030) were less likely to achieve a favorable outcome. Commonly used grading scales (e.g., Borden and Cognard) were not predictive of outcome. Female sex (OR 1.7, p = 0.03), absent venous ectasia (OR 3.4, p < 0.001), and cavernous carotid location (OR 2.1, p = 0.019) were predictors of GKRS-induced dAVF obliteration. CONCLUSIONS: GKRS for cerebral dAVFs achieved obliteration and avoided permanent complications in the majority of patients. Those with cavernous carotid location and no venous ectasia were more likely to have fistula obliteration following radiosurgery. Commonly used grading scales were not reliable predictors of outcome following radiosurgery.
引用
- Starke RM, McCarthy DJ, Chen CJ, et al. Evaluation of stereotactic radiosurgery for cerebral dural arteriovenous fistulas in a multicenter international consortium. J Neurosurg. 2019. PMID: 30611144. doi:10.3171/2018.8.JNS181467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。